Natera Inc. (($NTRA)) announced an update on their ongoing clinical study. Study Overview: Natera Inc. is conducting a study titled ‘EXpanding ...

Non-invasive prenatal testing (NIPT) on pregnant women to detect the risk of a fetus having rare genetic abnormalities may often be wrong, according to recent reports. These tests, according to ...

Fetuses at high risk for cystic fibrosis may be detected by screening of pregnant mothers using reflex to cell-free DNA analysis.

Medical scientists have demonstrated for the first time that it is possible to incorporate DNA analysis into antenatal screening for three serious chromosome disorders, including Down's syndrome, in a ...

Noninvasive prenatal testing by massive parallel sequencing of maternal plasma DNA has rapidly been adopted as a mainstream method for detection of fetal trisomy 21, 18 and 13. Despite the relative ...

We conducted a randomized trial in which pregnant women at a gestation of 15 weeks 6 days or less provided blood samples for measurement of thyrotropin and free thyroxine (T 4). Women were assigned to ...